| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Guyer William is a Chief Development Officer at Corcept Therapeutics Incorporated. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $116K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | CORT Corcept Therapeutics Incorporated | Chief Development Officer | Sale+OE | 20,000 | $40.97 | $819,400.00 | -90.0% | - | - | |
| Mar 4, 2026 | CORT Corcept Therapeutics Incorporated | Chief Development Officer | Sale+OE | 8,233 | $35.99 | $296,346.01 | -78.7% | - | - | |
| Feb 3, 2026 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 20,000 | $40.87 | $817,334.00 | -94.2% | +26.3% | - | |
| Jan 6, 2026 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 20,000 | $35.18 | $703,656.00 | -94.2% | +14.2% | - | |
| Dec 2, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 20,000 | $80.08 | $1,601,526.06 | -86.5% | -55.5% | - | |
| Nov 25, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sell | 4,500 | $80.90 | $364,070.25 | -85.1% | -56.0% | - | |
| Nov 5, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 20,000 | $75.36 | $1,507,121.70 | -40.3% | -46.9% | - | |
| Oct 7, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 20,000 | $89.94 | $1,798,782.00 | -79.1% | -61.3% | - | |
| Sep 2, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 20,000 | $70.49 | $1,409,848.25 | -56.5% | +11.8% | - | |
| Aug 8, 2025 | CORT Corcept Therapeutics Inc | Chief Development Officer | Sale+OE | 35,007 | $71.77 | $2,512,452.39 | -86.4% | +1.1% | - |